James Adjaye

Last updated
Prof.

James Adjaye
Born
James Affram Adjaye

(1964-11-11) 11 November 1964 (age 59)
Nationality Ghanaian British
Education
Alma mater
Occupation Academic
Known for
Scientific career
Fields
Institutions

James Affram Adjaye is a Ghanaian British Stem cell scientist. He is the Director of the Institute for Stem Cell Research and Regenerative Medicine at the Heinrich Heine University's faculty of medicine. [1] [2] [3] He also led the Molecular Embryology and Aging Group of the Max Planck Institute for Molecular Genetics situated in Berlin, Germany. [2] [4] [5]

Contents

Early life and education

Adjaye had his secondary at the Accra Academy in Ghana, and John Kelly Boys High School in the United Kingdom. He proceeded to the University College of Cardiff where he obtained his Bachelor of Science degree in biochemistry in 1987. [2] He then enrolled at the University of Sussex a year later for further studies in Biochemistry, there, he was awarded his Master of Science degree in biochemistry in 1989. For his doctorate degree, Adjaye enrolled at the King's College, London for his research in genetic manipulation and molecular biology spanning from 1989 to 1992. [2] Adjaye then joined the Max Planck Institute of Biophysical Chemistry in Goettingen, Germany in 1992 as a postdoctoral fellow. He worked in that capacity until 1995. In 1996, he had another postdoctoral fellowship at the Institute of Child Health, University College of London, he remained there until 2001. [5] [4]

Career

A year after his postdoctoral fellowship at the Institute of Child Health, University College of London, Adjaye joined the Max Planck Institute of Molecular Genetics in Berlin as the group leader of the Molecular Embryology and Aging Group. [6] [7] He has worked in this capacity to date. In 2012, he became a professor at the Heinrich Heine University Düsseldorf. [8] There, he is director of the Institute for Stem Cell Research and Regenerative Medicine of the university's Faculty of Medicine. He is the also the Chairs of Stem Cell Research and Regenerative Medicine. [5] [4] [8]

Research work and selected publications

Adjaye's research focuses on projects that are system biology-based nationally and internationally. He models human brain-(Nijmegen Breakage Syndrome, Bilirubin-induced neuronal damage and Alzheimer's disease) liver-NAFLD and kidney injury associated diseases using iPS cells (induced pluripotent stem cells). [4] [8] [9]

His works have been featured in journals such as the International Journal of Molecular Sciences , EMBO Reports , Stem Cell Research , Cell Reports , the Journal of Alzheimer's Disease , [4] and BMC Genomics .

Some of his works include;

Personal life

Prof. James Adjaye is married to Mrs. Theresa Adjaye who is by profession a Clinical Pharmacist/ Independent Prescriber specialising in cardiovascular disease. Together, they have 4 children.

He is the elder brother of the British architect Sir. David Adjaye. [10]

Related Research Articles

<span class="mw-page-title-main">Stem cell</span> Undifferentiated biological cells that can differentiate into specialized cells

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

Fred "Rusty" Gage is an American geneticist known for his discovery of stem cells in the adult human brain. Gage is a former president (2018–2023) of the Salk Institute for Biological Studies, where he holds the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease and works in the Laboratory of Genetics.

<span class="mw-page-title-main">James Thomson (cell biologist)</span> American developmental biologist

James Alexander Thomson is an American developmental biologist best known for deriving the first human embryonic stem cell line in 1998 and for deriving human induced pluripotent stem cells (iPS) in 2007.

<span class="mw-page-title-main">Stem-cell line</span> Culture of stem cells that can be propagated indefinitely

A stem cell line is a group of stem cells that is cultured in vitro and can be propagated indefinitely. Stem cell lines are derived from either animal or human tissues and come from one of three sources: embryonic stem cells, adult stem cells, or induced stem cells. They are commonly used in research and regenerative medicine.

In biology and medicine, stem cell genomics is the analysis of the genomes of stem cells. Currently, this field is rapidly expanding due to the dramatic decrease in the cost of sequencing genomes. The study of stem cell genomics has wide reaching implications in the study of stem cell biology and possible therapeutic usages of stem cells.

<span class="mw-page-title-main">Induced pluripotent stem cell</span> Pluripotent stem cell generated directly from a somatic cell

Induced pluripotent stem cells are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanaka and Kazutoshi Takahashi in Kyoto, Japan, who together showed in 2006 that the introduction of four specific genes, collectively known as Yamanaka factors, encoding transcription factors could convert somatic cells into pluripotent stem cells. Shinya Yamanaka was awarded the 2012 Nobel Prize along with Sir John Gurdon "for the discovery that mature cells can be reprogrammed to become pluripotent."

<span class="mw-page-title-main">Shinya Yamanaka</span> Japanese stem cell researcher

Shinya Yamanaka is a Japanese stem cell researcher and a Nobel Prize laureate. He is a professor and the director emeritus of Center for iPS Cell Research and Application, Kyoto University; as a senior investigator at the UCSF-affiliated Gladstone Institutes in San Francisco, California; and as a professor of anatomy at University of California, San Francisco (UCSF). Yamanaka is also a past president of the International Society for Stem Cell Research (ISSCR).

A biorepository is a facility that collects, catalogs, and stores samples of biological material for laboratory research. Biorepositories collect and manage specimens from animals, plants, and other living organisms. Biorepositories store many different types of specimens, including samples of blood, urine, tissue, cells, DNA, RNA, and proteins. If the samples are from people, they may be stored with medical information along with written consent to use the samples in laboratory studies.

Stem cell laws are the law rules, and policy governance concerning the sources, research, and uses in treatment of stem cells in humans. These laws have been the source of much controversy and vary significantly by country. In the European Union, stem cell research using the human embryo is permitted in Sweden, Spain, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however, it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving support. Elsewhere, Japan, India, Iran, Israel, South Korea, China, and Australia are supportive. However, New Zealand, most of Africa, and most of South America are restrictive.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

<span class="mw-page-title-main">Cell potency</span> Ability of a cell to differentiate into other cell types

Cell potency is a cell's ability to differentiate into other cell types. The more cell types a cell can differentiate into, the greater its potency. Potency is also described as the gene activation potential within a cell, which like a continuum, begins with totipotency to designate a cell with the most differentiation potential, pluripotency, multipotency, oligopotency, and finally unipotency.

Induced stem cells (iSC) are stem cells derived from somatic, reproductive, pluripotent or other cell types by deliberate epigenetic reprogramming. They are classified as either totipotent (iTC), pluripotent (iPSC) or progenitor or unipotent – (iUSC) according to their developmental potential and degree of dedifferentiation. Progenitors are obtained by so-called direct reprogramming or directed differentiation and are also called induced somatic stem cells.

<span class="mw-page-title-main">Cellular Dynamics International</span> Biotechnology company

Fujifilm Cellular Dynamics, Inc. (FCDI) is a large scale manufacturer of human cells, created from induced pluripotent stem cells, for use in basic research, drug discovery and regenerative medicine applications.

Directed differentiation is a bioengineering methodology at the interface of stem cell biology, developmental biology and tissue engineering. It is essentially harnessing the potential of stem cells by constraining their differentiation in vitro toward a specific cell type or tissue of interest. Stem cells are by definition pluripotent, able to differentiate into several cell types such as neurons, cardiomyocytes, hepatocytes, etc. Efficient directed differentiation requires a detailed understanding of the lineage and cell fate decision, often provided by developmental biology.

<span class="mw-page-title-main">Jeanne Loring</span> American biologist

Jeanne Frances Loring is an American stem cell biologist, developmental neurobiologist, and geneticist. She is the founding Director of the Center for Regenerative Medicine and emeritus professor at the Scripps Research Institute in La Jolla, California. She has founded two biotechnology companies, Arcos BioScience (1999) and Aspen Neuroscience (2018)

Masayo Takahashi is a Japanese medical physician, ophthalmologist and stem cell researcher.

Kristin K. Baldwin is an American scientist who is a professor at the Department of Genetics and Development at Columbia University. Her research focuses on using reprogrammed and induced pluripotent stem cells to identify mechanisms and therapies related to human genetic risk for neurologic and cardiovascular disease. Her lab also studies how disease and aging affect the genome; they have used cloning to produce the first complete genome sequence of a single neuron and helped assess the effect of aging on induced pluripotent stem cells that may be used for cell therapies. They also design bespoke neuronal cells in a dish to understand brain function and disease. Baldwin's earlier work included being the first to clone a mouse from a neuron and being one of three groups to first produce an entire mouse from a skin cell by generating induced pluripotent stem cells. epigenetic changes of the genome and the brain.

The European Bank for induced pluripotent Stem Cells (EBiSC) is a non-profit induced pluripotent stem cell (iPSC) biorepository and service provider with central facilities in Germany and the United Kingdom.

<span class="mw-page-title-main">Experimental models of Alzheimer's disease</span>

Experimental models of Alzheimer's disease are organism or cellular models used in research to investigate biological questions about Alzheimer's disease as well as develop and test novel therapeutic treatments. Alzheimer's disease is a progressive neurodegenerative disorder associated with aging, which occurs both sporadically or due to familial passed mutations in genes associated with Alzheimer's pathology. Common symptoms associated with Alzheimer's disease include: memory loss, confusion, and mood changes.

Valentina Fossati is an Italian stem cell biologist. She is a Senior Research Investigator at the New York Stem Cell Foundation. Her research is focused on developing human stem cell-based models to study the role of glia in neurodegeneration and neuroinflammation.

References

  1. "Molecular Embryology and Aging Group (James Adjaye)". www.molgen.mpg.de. Retrieved 2022-03-07.
  2. 1 2 3 4 "James Adjaye, Chair of Stem Cell Research, Heinrich Heine University". Drug Target Review. Retrieved 2022-03-07.
  3. Brand-Saberi, Beate (2020-01-03). Essential Current Concepts in Stem Cell Biology. Springer Nature. ISBN   978-3-030-33923-4.
  4. 1 2 3 4 5 6 "James Adjaye, PhD | Journal of Alzheimer's Disease". www.j-alz.com. Retrieved 2022-03-07.
  5. 1 2 3 "Institut für Stammzellforschung und Regenerative Medizin". UKD (in German). Retrieved 2022-03-07.
  6. Methods in Systems Biology. Academic Press. 2011-09-19. ISBN   978-0-12-385119-2.
  7. Thornhill, Alan (2007). Single Cell Diagnostics: Methods and Protocols. Springer Science & Business Media. ISBN   978-1-59745-298-4.
  8. 1 2 3 Andriani, Daskalaki (2012-11-30). Medical Advancements in Aging and Regenerative Technologies: Clinical Tools and Applications: Clinical Tools and Applications. IGI Global. ISBN   978-1-4666-2507-5.
  9. 1 2 Research, Director of the Institute for Stem Cell; Research, Regenerative MedicineProf Dr James Adjaye Institute for Stem Cell; Düsseldorf, Regenerative MedicineHeinrich-Heine-University Moorenstraße 5 40225. "Universität Düsseldorf: James Adjaye". www.neurosciences-duesseldorf.de. Retrieved 2022-03-07.{{cite web}}: CS1 maint: numeric names: authors list (link)
  10. "Dirty house music: how David Adjaye's DJ brother turns his buildings into beats". the Guardian. 2016-07-14. Retrieved 2022-07-26.